Skip to main content
. 2011 Jul 24;52(7):461–465. doi: 10.4111/kju.2011.52.7.461

TABLE 2.

Comparisons of clinical factors in responders and nonresponders to second-line MAB

graphic file with name kju-52-461-i002.jpg

AWS: antiandrogen withdrawal syndrome, CR: complete response, MAB: maximum androgen blockade, PR: partial response, PSA: prostate-specific antigen, a: ANOVA, b: chi-square test (with Fisher's exact test), c: a Gleason score could not be determined in one patient with mucinous prostate adenocarcinoma.